# Atofil LLC – FDA Inspection, Jan 25, 2024

Source: https://www.keypedia.com/records/fda_inspections/atofil-llc/739c4418-37d1-4145-84cb-b517135914cb
Source feed: FDA_Inspections

> FDA inspection 1227982 of Atofil LLC, January 25, 2024. 1 citation under 21 CFR part 211. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1227982
- Company Name: Atofil LLC
- Inspection Date: 2024-01-25
- Project Area: Unapproved and Misbranded Drugs
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Florida District Office
- Citation Count: 1

## Related Documents

- [FDA Inspection 1136458 - 2021-03-10](https://www.keypedia.com/records/fda_inspections/atofil-llc/fc3e368a-3192-4adf-ac2e-8bf7b04a709d)

## Related Officers

- [Oluwasefunm Agbanigo](https://www.keypedia.com/people/oluwasefunm-agbanigo/a25367a6-c32e-4706-9299-e90a15da2e95)
- [FDA Associated Person](https://www.keypedia.com/people/saundrea-a-munroe/129a869f-e1f2-4d59-b3ed-9613a9190f8a)

Company: https://www.keypedia.com/companies/atofil-llc/5547ddad-373d-471c-84c1-f2c6313d2180

Office: https://www.keypedia.com/offices/florida-district-office/95b2a118-0b78-46e0-a54c-982bd7ce51c9